{"id":3988,"date":"2026-10-29T09:00:00","date_gmt":"2026-10-29T13:00:00","guid":{"rendered":"https:\/\/www.insilens.com\/?p=3988"},"modified":"2026-10-29T20:08:24","modified_gmt":"2026-10-30T00:08:24","slug":"mettl13-links-codon-decoding-to-kras-resistance","status":"publish","type":"post","link":"https:\/\/www.insilens.com\/?p=3988","title":{"rendered":"METTL13 Links Codon Decoding to KRAS Resistance"},"content":{"rendered":"

\"\"<\/p>\n

Company<\/strong><\/p>\n

Academic investigators (Nature Cell Biology)<\/p>\n

Event Type<\/strong><\/p>\n

Peer-reviewed publication<\/p>\n

Modality<\/strong><\/p>\n

Target biology (translation-elongation methyltransferase)<\/p>\n

Asset<\/strong><\/p>\n

METTL13\u2013eEF1A K55me2 axis<\/p>\n

Target<\/strong><\/p>\n

METTL13; eEF1A; KRAS translation<\/p>\n

Disease Area<\/strong><\/p>\n

KRAS-driven lung cancer (resistance)<\/p>\n

Summary<\/h4>\n

An online-first peer-reviewed Nature Cell Biology paper dated 29 October reports that METTL13-mediated dimethylation of eEF1A at K55 changes decoding of rare codons and increases translation of oncogenic proteins including KRAS. The work proposes a mechanistic source of KRAS-inhibitor resistance, not a validated drug.<\/p>\n

The journal\u2019s advance article and research index describe selective translation of codon-biased transcripts rather than a global increase in all proteins. The authors connect the METTL13\u2013eEF1A K55me2 axis to KRAS protein production and inhibitor resistance in lung cancer models. This is an accepted early online paper; issue assignment and later copy edits may differ from 29 October online publication. No clinical METTL13-inhibitor data are reported.<\/p>\n

Deep Analysis<\/h4>\n

The biological distinction matters: translation elongation can alter oncogene abundance without a DNA mutation or new transcriptional program. A pharmacologic METTL13 inhibitor could in principle resensitize some RAS-driven tumors, but enzyme selectivity, cell and tumor exposure, and effects on normal high-turnover tissues are unresolved. eEF1A is broadly essential, so therapeutic index may be narrow. Patient-relevant resistance frequency, validated phosphoproteomic biomarkers, in-vivo druglike perturbation and duration of response remain necessary. An academic mechanism alone does not establish a treatment-ready modality or startup-quality IP position.<\/p>\n

Company and Product Background<\/h4>\n

METTL13 methylates the elongation factor eEF1A; K55 dimethylation can favor decoding of selected codons. KRAS-driven tumors may exploit altered translation to maintain oncogenic signaling under inhibitor pressure.<\/p>\n

Signal Extraction<\/h4>\n
    \n
  • Interpretation A:<\/strong> codon-specific translation is an actionable resistance layer; convergent mechanistic experiments support it.<\/li>\n
  • Interpretation B:<\/strong> model-specific protein-expression shifts may not dominate clinical resistance.<\/li>\n
  • Upgrade<\/strong> with independent patient cohorts, selective chemical probes and normal-tissue window. Downgrade<\/strong> with no effect at tolerable exposure or poor biomarker prevalence. Resistance persistence after selective METTL13 suppression would falsify<\/strong> a broad resensitization claim.<\/li>\n<\/ul>\n

    InSilens Take<\/h4>\n

    Inference: the paper expands target space for oncology resistance, while druggability and clinical relevance remain uncertain.<\/p>\n

    Signal Assessment<\/h4>\n

    Signal Importance: 4 of 5. Signal Direction: positive mechanistic evidence; clinical uncertain. Confidence in Facts: moderate to high. Confidence in Interpretation: moderate to low.<\/p>\n","protected":false},"excerpt":{"rendered":"

    An online-first peer-reviewed Nature Cell Biology paper dated 29 October reports that METTL13-mediated dimethylation of eEF1A at K55 changes decoding of rare codons and increases translation of oncogenic proteins including KRAS. The work proposes…<\/p>\n","protected":false},"author":1,"featured_media":3990,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[1295,1179,1294,1297,1296],"class_list":["post-3988","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-technology-modalities","tag-eef1a","tag-kras","tag-mettl13","tag-nature-cell-biology","tag-translation-regulation"],"blocksy_meta":[],"_links":{"self":[{"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/posts\/3988","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3988"}],"version-history":[{"count":1,"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/posts\/3988\/revisions"}],"predecessor-version":[{"id":4000,"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/posts\/3988\/revisions\/4000"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/media\/3990"}],"wp:attachment":[{"href":"https:\/\/www.insilens.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3988"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3988"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3988"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}